Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Richter

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Pain and Symptom Management|October 17, 2016
Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment-A Randomized Controlled TrialMarkus K Schuler, Leopold Hentschel, Wadim Kisel, et al.
Cancers|March 28, 2026
The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa StudyMartin Eichler, Rebekka Hoffmann, Christina Baumgarten, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2019
Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffoldAdrian Wlodarczak, Luis Antonio Iñigo Garcia, Pasi P Karjalainen, et al.
Nucleic Acids Research|December 17, 2025
VirJenDB: a FAIR (meta)data and bioinformatics platform for all virusesShahram Saghaei, Malte Siemers, Kilian L Ossetek, et al.
BMC Cancer|August 11, 2016
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patientsMarkus K Schuler, Sebastian Gerdes, Antje West, et al.
Therapeutic Advances in Neurological Disorders|February 12, 2025
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world studyTjalf Ziemssen, Ann D Bass, Bart Van Wijmeersch, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Cancers|April 3, 2021
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient<sup>®</sup> in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)Daniel Pink, Dimosthenis Andreou, Sebastian Bauer, et al.
European Heart Journal. Acute Cardiovascular Care|April 12, 2023
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shockUwe Zeymer, Christiane Lober, Stephan Richter, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injurySandra Heuschkel, Theresa Kretschmann, Raphael Teipel, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Pain and Symptom Management|October 17, 2016
Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment-A Randomized Controlled TrialMarkus K Schuler, Leopold Hentschel, Wadim Kisel, et al.
Cancers|March 28, 2026
The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa StudyMartin Eichler, Rebekka Hoffmann, Christina Baumgarten, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 6, 2019
Magnesium 2000 postmarket evaluation: Guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffoldAdrian Wlodarczak, Luis Antonio Iñigo Garcia, Pasi P Karjalainen, et al.
Nucleic Acids Research|December 17, 2025
VirJenDB: a FAIR (meta)data and bioinformatics platform for all virusesShahram Saghaei, Malte Siemers, Kilian L Ossetek, et al.
BMC Cancer|August 11, 2016
Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patientsMarkus K Schuler, Sebastian Gerdes, Antje West, et al.
Therapeutic Advances in Neurological Disorders|February 12, 2025
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world studyTjalf Ziemssen, Ann D Bass, Bart Van Wijmeersch, et al.
Journal of Cancer Research and Clinical Oncology|December 16, 2019
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case seriesChristoph Oing, Marcus Hentrich, Anja Lorch, et al.
Cancers|April 3, 2021
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient<sup>®</sup> in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)Daniel Pink, Dimosthenis Andreou, Sebastian Bauer, et al.
European Heart Journal. Acute Cardiovascular Care|April 12, 2023
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shockUwe Zeymer, Christiane Lober, Stephan Richter, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injurySandra Heuschkel, Theresa Kretschmann, Raphael Teipel, et al.
Pageof 7